http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BioLife Solutions Appoints Joydeep Goswami, MBA, PhD to Board of Directors
-
BioLife Solutions (BLFS) Announces CFO Retirement
-
BioLife Solutions Announces CFO Retirement
-
BioLife Solutions (BLFS) to Register 10.7M Shares Related to Completed Acquisition
-
BioLife Solutions Files Form S-3 Registration Statement to Register Shares from Completed Acquisitions
-
BioLife Solutions Closes Acquisition of Sexton Biotechnologies
-
BioLife Solutions Joins S&P SmallCap 600 Index
-
BioLife Solutions Announces Second Quarter 2021 Financial Results
-
Sexton Biotechnologies to be Acquired by Biolife Solutions
-
BioLife Solutions (BLFS) Acquires Sexton Biotechnologies for $24M
-
BioLife Solutions to Acquire Sexton Biotechnologies to Expand Cell and Gene Therapy Tools Portfolio
-
BioLife Solutions to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021
-
BioLife Solutions (BLFS) Announces Raymond W. Cohen Resignation from Board; Appointment of Mike Rice
-
BioLife Solutions Announces Changes to Board of Directors
-
BioLife Solutions Adopts New Brand Identity
-
BioLife Solutions Announces Promotion of Caitlin Rice to Global Vice President, Customer Service
-
BioLife Solutions Announces First Quarter 2021 Financial Results
-
BioLife Solutions to Report First Quarter 2021 Financial Results and Provide Business Update on May 13, 2021
-
BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Biopharma CDMO
-
BioLife Solutions Launches New High Capacity Controlled Rate Freezer Line with First Shipment to a Leading Cell Therapy Developer
-
BioLife Solutions Appoints Two New Independent Board Directors
-
Stirling Ultracold Announces Merger Agreement with BioLife Solutions to Further Support Life-Science Industry with Expertise in Ultra-Low Temperature Storage
-
BioLife Solutions Announces Fourth Quarter and Full Year 2020 Financial Results
-
BioLife Solutions (BLFS) to Acquire Stirling Ultracold in All-Stock Deal
-
BioLife Solutions to Acquire Stirling Ultracold in an All-Stock Merger
-
BioLife Solutions to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Business Update on March 22, 2021
-
BioLife Solutions Promotes Marcus Schulz to Chief Revenue Officer
-
BioLife Solutions Promotes Sarah Aebersold, J.D. to Global Vice President, Human Resources
-
BioLife Solutions & Casdin Capital Innovation Accelerator Announce New Investments in Cell & Gene Therapy Bioproduction Tools
-
iVexSol Announces Series A Funding
-
BioLife Solutions Ranked 403rd Fastest Growing Company in North America on Deloitte's 2020 Technology Fast 500™
-
BioLife Solutions Announces Third Quarter 2020 Financial Results
-
BioLife Solutions to Report Third Quarter 2020 Financial Results and Provide Business Update on November 5, 2020
-
BioLife Solutions (BLFS) Announces SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines
-
BioLife Solutions SciSafe Division Secures $2.7 Million Cold Chain and Storage Contract for COVID-19 Vaccines
-
BioLife Solutions Closes Acquisition of SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
-
BioLife Solutions to Acquire SciSafe, a High-Growth Biostorage Service Provider to the Cell and Gene Therapy Industry
-
BioLife Solutions Named one of the Top 100 Companies in Washington State
-
BioLife Solutions Announces Second Quarter 2020 Financial Results
-
BioLife Solutions to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
-
BioLife Solutions evo® Cold Chain Management Platform Now Supporting Over 100 Early Stage Cell & Gene Therapy Clinical Trials
-
BioLife Solutions Announces Closing of $86 Million Public Offering of Common Stock
-
BioLife Solutions (BLFS) Prices 5.18M Share Common Stock Offering at $14.50/sh
-
BioLife Solutions Announces Pricing of $75 Million Public Offering of Common Stock
-
BioLife Solutions Announces $9.6 Million to $9.8 Million in Preliminary Revenue for Q2 2020
-
BioLife Solutions (BLFS) to Offer Common Stock
-
BioLife Solutions Announces Proposed Public Offering of Common Stock
-
BioLife Solutions Promotes Marcus Schulz to Vice President, Global Sales
-
BioLife Solutions Announces First Quarter 2020 Financial Results
-
BioLife Solutions to Report First Quarter 2020 Financial Results and Provide Business Update on May 14th, 2020

